Organon Pharma Indonesia Tbk PT banner
O

Organon Pharma Indonesia Tbk PT
IDX:SCPI

Watchlist Manager
Organon Pharma Indonesia Tbk PT
IDX:SCPI
Watchlist
Price: 29 000 IDR Market Closed
Market Cap: Rp104.4B

Organon Pharma Indonesia Tbk PT
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Organon Pharma Indonesia Tbk PT
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
O
Organon Pharma Indonesia Tbk PT
IDX:SCPI
Inventory
Rp645.1B
CAGR 3-Years
30%
CAGR 5-Years
16%
CAGR 10-Years
6%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Inventory
Rp2.3T
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
7%
Kalbe Farma Tbk PT
IDX:KLBF
Inventory
Rp7T
CAGR 3-Years
0%
CAGR 5-Years
14%
CAGR 10-Years
9%
Soho Global Health Tbk PT
IDX:SOHO
Inventory
Rp1.6T
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Pyridam Farma Tbk PT
IDX:PYFA
Inventory
Rp492.1B
CAGR 3-Years
36%
CAGR 5-Years
54%
CAGR 10-Years
29%
Kimia Farma Tbk PT
IDX:KAEF
Inventory
Rp1.3T
CAGR 3-Years
-26%
CAGR 5-Years
-12%
CAGR 10-Years
6%
No Stocks Found

Organon Pharma Indonesia Tbk PT
Glance View

Market Cap
104.4B IDR
Industry
Pharmaceuticals

PT Organon Pharma Indonesia Tbk engages in the development, manufacture, and distribution of pharmaceutical products. The company is headquartered in Jakarta Pusat, Dki Jakarta. The firm is engaged in the processing, packaging and development of pharmaceutical products for human and animal consumption, toiletries, cosmetics, household and related products. The firm is also engaged in importing of raw materials, finished goods and providing business and management consultancy services. The Company’s segments include Pharmaceutical Manufacturing and commercial. For women's health, the Company develops product specifically for women, including contraception, fertility, pregnancy management, perinatal diseases and other diseases. The Company’s subsidiaries include Organon LLC, PT Merck Sharp & Dohme Indonesia, Merck Sharp & Dohme Corp and Merck Sharp & Dohme Asia.

SCPI Intrinsic Value
Not Available
O

See Also

What is Organon Pharma Indonesia Tbk PT's Inventory?
Inventory
645.1B IDR

Based on the financial report for Sep 30, 2025, Organon Pharma Indonesia Tbk PT's Inventory amounts to 645.1B IDR.

What is Organon Pharma Indonesia Tbk PT's Inventory growth rate?
Inventory CAGR 10Y
6%

Over the last year, the Inventory growth was 25%. The average annual Inventory growth rates for Organon Pharma Indonesia Tbk PT have been 30% over the past three years , 16% over the past five years , and 6% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett